Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Poli

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Scientific Reports|September 26, 2018
Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 PolarizationFrancesca Graziano, Giulia Aimola, Greta Forlani, et al.
AIDS (London, England)|June 17, 2005
Pertussis toxin B-oligomer dissociates T cell activation and HIV replication in CD4 T cells released from infected lymphoid tissueMassimo Alfano, Jean-Charles Grivel, Silvia Ghezzi, et al.
European Journal of Immunology|February 21, 2003
Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infectionPriscilla Biswas, Marina Ferrarini, Barbara Mantelli, et al.
Journal of Translational Medicine|April 20, 2016
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cellsGreta Forlani, Filippo Turrini, Silvia Ghezzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
Pertussis toxin B-oligomer suppresses IL-6 induced HIV-1 and chemokine expression in chronically infected U1 cells via inhibition of activator protein 1Chiara Rizzi, Massimo P Crippa, Rienk E Jeeninga, et al.
Journal of Virus Eradication|August 3, 2016
Highlights from the Seventh International Workshop on HIV Persistence during Therapy, 8-11 December 2015, Miami, Florida, USADavid M Margolis, Karl Salzwedel, Nicolas Chomont, et al.
Vaccine|April 23, 2003
Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmids and virus-like particles in prime-boost vaccination protocols against SHIVAntonia Radaelli, Carlo Zanotto, Gianpaolo Perletti, et al.
Cytokine|March 12, 2002
Interleukin (IL)-4 inhibits phorbol-ester induced HIV-1 expression in chronically infected U1 cells independently from the autocrine effect of endogenous tumour necrosis factor-alpha, IL-1beta, and IL-1 receptor antagonistDelia Goletti, Audrey L Kinter, Eliana M Coccia, et al.
AIDS (London, England)|July 11, 2003
Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administrationSimona Porcellini, Giuliana Vallanti, Silvia Nozza, et al.
Blood|October 26, 2006
Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replicationElisabetta Pilotti, Lisa Elviri, Elisa Vicenzi, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Scientific Reports|September 26, 2018
Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 PolarizationFrancesca Graziano, Giulia Aimola, Greta Forlani, et al.
AIDS (London, England)|June 17, 2005
Pertussis toxin B-oligomer dissociates T cell activation and HIV replication in CD4 T cells released from infected lymphoid tissueMassimo Alfano, Jean-Charles Grivel, Silvia Ghezzi, et al.
European Journal of Immunology|February 21, 2003
Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infectionPriscilla Biswas, Marina Ferrarini, Barbara Mantelli, et al.
Journal of Translational Medicine|April 20, 2016
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cellsGreta Forlani, Filippo Turrini, Silvia Ghezzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
Pertussis toxin B-oligomer suppresses IL-6 induced HIV-1 and chemokine expression in chronically infected U1 cells via inhibition of activator protein 1Chiara Rizzi, Massimo P Crippa, Rienk E Jeeninga, et al.
Journal of Virus Eradication|August 3, 2016
Highlights from the Seventh International Workshop on HIV Persistence during Therapy, 8-11 December 2015, Miami, Florida, USADavid M Margolis, Karl Salzwedel, Nicolas Chomont, et al.
Vaccine|April 23, 2003
Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmids and virus-like particles in prime-boost vaccination protocols against SHIVAntonia Radaelli, Carlo Zanotto, Gianpaolo Perletti, et al.
Cytokine|March 12, 2002
Interleukin (IL)-4 inhibits phorbol-ester induced HIV-1 expression in chronically infected U1 cells independently from the autocrine effect of endogenous tumour necrosis factor-alpha, IL-1beta, and IL-1 receptor antagonistDelia Goletti, Audrey L Kinter, Eliana M Coccia, et al.
AIDS (London, England)|July 11, 2003
Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administrationSimona Porcellini, Giuliana Vallanti, Silvia Nozza, et al.
Blood|October 26, 2006
Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replicationElisabetta Pilotti, Lisa Elviri, Elisa Vicenzi, et al.
Pageof 13